Sugar Crush: And Now, The Rest of the Story...

Atherosclerosis. Multiple sclerosis. Amyotrophic lateral sclerosis.

Three very different diagnoses—but they all contain the same word.

Why?

On this episode of Sugar Crush: The Rest of the Story, Dr. Rick Jacoby starts with the Greek origins of sclerosis, meaning “hardening,” and follows that thread through more than 150 years of medical history to ask a provocative question: Could diseases we treat as completely separate conditions share pieces of the same underlying biological process? 

Drawing on his decades of work with diabetic neuropathy and peripheral nerve surgery, Dr. Rick lays out his Global Compression Theory. He discusses inflammation, fibrosis, glycation, the polyol pathway, nitric oxide, oxygen deprivation, and the physical compression of nerves—and explains why he believes sugar plays a central role in that process. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Peptides are booming. Patients want them. Practitioners are using them. Regulators are scrutinizing them. And Dr. Rick Jacoby believes the debate raises a much bigger question:

Who gets to decide what the future of medicine looks like?

On this episode of Sugar Crush: The Rest of the Story, Dr. Rick and Grok dive back into the rapidly evolving world of peptides, beginning with one of the most talked-about compounds in regenerative medicine: BPC-157.

They explore what peptides are, how these short chains of amino acids act as biological signals, why BPC-157 has attracted so much attention, and the legitimate concerns surrounding sourcing, purity, manufacturing standards, and the limited amount of rigorous human clinical data currently available. 

But rather than simply choosing between unrestricted access and prohibition, Dr. Rick proposes another approach: create guardrails, track outcomes, and collect real-world evidence. He makes the case for a national registry that could anonymously follow peptide use, practitioners, products, outcomes, and adverse events—potentially generating a massive pool of data about how these therapies are actually being used.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What do sugar, nerve compression, recurrent UTIs, the vaginal microbiome, and a nerve whose name literally comes from the Latin word for “shame” have in common?

On this episode of Sugar Crush: The Rest of the Story, Dr. Rick Jacoby ventures into a subject that doesn't get nearly enough attention: the relationship between metabolic health, the nervous system, and women's pelvic health.

Inspired by a recent conversation surrounding longevity enthusiast Bryan Johnson and the vaginal microbiome, Dr. Rick turns his attention to the pudendal nerve - a major pelvic nerve responsible for sensory and motor functions involving the perineum, vulva, clitoris, and surrounding structures. Its name even traces back to the Latin pudendus, meaning “to be ashamed.” 

Drawing on his background in peripheral nerve surgery and his work with diabetic neuropathy, Dr. Rick explains his global compression theory and explores whether some pelvic symptoms can be viewed through the same nerve-compression framework he applies elsewhere in the body. He discusses glycation, circulation, nerve compression, microbiome changes, itching and burning, pelvic pain, and recurrent urinary and vaginal symptoms. 

The conversation also examines the complicated relationship between antibiotics, bacteria, yeast, medications, diet, and recurrent UTIs, while Dr. Rick challenges conventional thinking about whether treating symptoms alone always addresses their underlying cause. 

It's an unconventional - and at times deliberately provocative - look at women's health through the lens of nerves, metabolism, and microbiology.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if extending human life isn't just about keeping the heart beating? What if the bigger challenge is understanding the electrical signals, consciousness, and biological systems that make us who we are?

On this episode of Sugar Crush: The Rest of the Story, Dr. Rick Jacoby takes one of his most ambitious journeys yet - exploring the intersection of longevity, cryonics, consciousness, bioelectricity, regenerative medicine, and the human body's remarkable capacity for repair.

The conversation begins practically in Dr. Rick's backyard at Scottsdale's Alcor cryonics facility, where people - including baseball legend Ted Williams—have been cryopreserved in hopes that future technology may someday make restoration possible. That raises a question far more complicated than simply preserving tissue: If a body could someday be restored, would the person—and their consciousness—return with it?

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Peptides are suddenly everywhere. Doctors are talking about them, patients are asking about them, and regulators are debating what should—and shouldn't—be available. But are peptides really something new?

On this episode of Sugar Crush: The Rest of the Story, Dr. Rick Jacoby and Grok take a deep dive into the rapidly growing world of peptides and regenerative medicine, beginning with an intriguing question: What does “licking your wounds” have to do with modern medicine?

From Pavlov's research into gastric secretions to BPC-157 and other peptides, Dr. Rick explores the idea that scientists may be uncovering mechanisms connected to healing processes that have existed in nature for millions of years. The conversation examines what peptides are, their relationship to amino acids and growth factors, and how Dr. Rick views their connection to stem cells and the body's signaling and repair systems. 

The discussion then turns to the controversy surrounding regulation. Dr. Rick challenges the way regenerative therapies are classified in the United States, discusses FDA Sections 351 and 361, revisits historical discussions surrounding non-embryonic stem cells, and argues for greater transparency and continued research as policymakers consider how peptides should be regulated. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Stem cells are being used and marketed around the world—but what’s actually allowed, what does the science say, and how can patients separate promising regenerative medicine from expensive hype?

On this episode of Sugar Crush: The Rest of the Story, Dr. Rick Jacoby welcomes an unusual co-host - “Chat" - for a wide-ranging conversation about the evolving world of stem cells and regenerative medicine.

Dr. Rick explores the differences between FDA Sections 351 and 361, minimally manipulated tissue, homologous use, Wharton’s jelly, emerging MUSE cells, PRP, bone marrow-derived treatments, and other regenerative approaches. The conversation also goes global, comparing regulatory environments in the United States, Canada, Mexico, the United Kingdom, Japan, Panama, and beyond. 

They also tackle the booming world of stem-cell medical tourism: Why do patients travel internationally for treatment? Does a higher price mean a better therapy? What questions should consumers ask before choosing a clinic? And how can patients distinguish between what’s being advertised and what has actually been demonstrated through research? 

Finally, Dr. Rick shares his own experiences with regenerative treatments and looks at the continuum from PRP and traditional approaches to newer cell-based therapies—while emphasizing the importance of understanding the evidence, regulatory status, potential costs, and available options before making a decision. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Pod Populi, Dr. Rick Jacoby and co-host Grok explore cutting-edge, surgery-free solutions for joint health. They discuss revolutionary laser technology, the healing potential of biologics like Wharton's Jelly, and simple dietary hacks such as glycine supplementation. Along the way, they challenge outdated nutrition advice and advocate for making America healthy again—one joint at a time.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode of Sugar Crush explores the hidden dangers of sugar and environmental toxins in professional sports, focusing on the high rate of Achilles tendon injuries among NFL players—especially the San Francisco 49ers. Dr. Rick and co-host Grok discuss how high sugar intake, glyphosate exposure, and electromagnetic fields may combine to damage nerves and tendons, referencing theories by Dr. Martin Pall and Dr. Stephanie Seneff. The hosts advocate for glycine—an amino acid with protective benefits—as a simple, overlooked solution to counteract these effects. They suggest that swapping sugary sports drinks for glycine could help athletes reduce injury risk and improve recovery.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Sugar Crush, Dr. Rick Jacoby and co-host Grok explore how everyday substances like glyphosate and sugar may contribute to nerve damage, metabolic syndrome, and even fungal toenail infections. They discuss the "global compression theory," connecting seemingly simple conditions to larger systemic issues, and question why crucial research on glyphosate's neurological impact remains neglected. With engaging metaphors and deep biochemistry, the hosts advocate for dietary glycine as a potential counter to widespread health problems and urge for further scientific investigation.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode explores the complicated landscape of stem cell therapy regulation in the United States, focusing on the FDA's restrictive definitions and their impact on doctors and patients. Dr. Rick Jacoby and his guest discuss the legal hurdles that drive Americans to seek treatment abroad, the role of big pharma, and the challenges of pursuing innovation. The conversation highlights the tension between scientific potential and regulatory roadblocks, leaving many to question the future of regenerative medicine in America.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.